McKesson to distribute injectables to MD offices through General Medical marketing force.
McKESSON WILL USE GENERAL MEDICAL FIELD FORCE TO MARKET INJECTABLES to physician office-based practices, McKesson CEO Mark Pulido reported during a Jan. 28 teleconference. Richmond, Va.-based General Medical has 500 account representatives who call on physicians' offices as part of the company's medical and surgical supply distribution business. McKesson is buying General Medical, "the nation's leading supplier to the full range of alternate-site health care facilities" and "the third-largest distributor of medical-surgical supplies to hospitals," for a total of $775 mil. in cash, stock and debt, the company announced.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth